TapewireFind a company

person · Reporting owner

Scimeca Dario

Disclosed activity across 1 company

Tapewire entity
41766
SEC CIK
0001779581

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
PRECISION BIOSCIENCES INCDTIL · Entity 6284General Counsel and SecretaryJune 01, 2026June 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

PRECISION BIOSCIENCES INC

Report date June 01, 2026 · Filed June 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect107,604 Reported balance After 2026-06-01 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-06-01 · Grant · Acquired 107,604 · Balance 107,604

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2: Award vests in three substantially equal annual installments beginning on February 18, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2: Award vests in three substantially equal annual installments beginning on February 18, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 01, 2026 Filed Jun 3, 2026 16:06 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 GrantRestricted Stock Units · Derivative 107,604 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-040220 · wk-form4_1780517173.xml · derivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,604

Underlying: Common Stock · 107,604 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: Award vests in three substantially equal annual installments beginning on February 18, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F2 · derivative.expiration_date: Award vests in three substantially equal annual installments beginning on February 18, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
February 18, 2026 Filed Feb 19, 2026 16:30 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 SaleCommon Stock 4,925 $3.84 $18,912.00
Disclosure

SEC source: 0001628280-26-009802 · wk-form4_1771536649.xml · nonDerivative · entry 2

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,457

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on September 29, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 16:30 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionRestricted Stock Units · Derivative 16,667 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-009802 · wk-form4_1771536649.xml · derivative · entry 3

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,333

Underlying: Common Stock · 16,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: RSUs vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: RSUs vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 16:30 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionCommon Stock 16,667 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-009802 · wk-form4_1771536649.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,382

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on February 17, 2026.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 21, 2026 Filed Jan 22, 2026 18:48 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 SaleCommon Stock 8,854 $4.03 $35,681.62
Disclosure

SEC source: 0001628280-26-003148 · wk-form4_1769125727.xml · nonDerivative · entry 4

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,715

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on September 29, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

Read SEC document
January 20, 2026 Filed Jan 22, 2026 18:48 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionRestricted Stock Units · Derivative 14,908 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-003148 · wk-form4_1769125727.xml · derivative · entry 7

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,907

Underlying: Common Stock · 14,908 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F6 · derivative.exercise_date: On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F6 · derivative.expiration_date: On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
January 20, 2026 Filed Jan 22, 2026 18:48 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionRestricted Stock Units · Derivative 8,425 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-003148 · wk-form4_1769125727.xml · derivative · entry 6

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,425

Underlying: Common Stock · 8,425 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F5 · derivative.expiration_date: On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
January 20, 2026 Filed Jan 22, 2026 18:48 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionRestricted Stock Units · Derivative 1,978 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-003148 · wk-form4_1769125727.xml · derivative · entry 5

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,978 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On January 20, 2023 the Reporting Person was granted RSUs, which vested in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: On January 20, 2023 the Reporting Person was granted RSUs, which vested in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
January 20, 2026 Filed Jan 22, 2026 18:48 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionCommon Stock 14,908 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-003148 · wk-form4_1769125727.xml · nonDerivative · entry 3

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,569

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on January 20, 2026.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 20, 2026 Filed Jan 22, 2026 18:48 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionCommon Stock 8,425 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-003148 · wk-form4_1769125727.xml · nonDerivative · entry 2

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,661

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on January 20, 2026.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 20, 2026 Filed Jan 22, 2026 18:48 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionCommon Stock 1,978 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-003148 · wk-form4_1769125727.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,236

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on January 20, 2026.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
November 03, 2025 Filed Nov 4, 2025 16:15 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 SaleCommon Stock 665 $6.49 $4,315.85
Disclosure

SEC source: 0001628280-25-048856 · wk-form4_1762290934.xml · nonDerivative · entry 2

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,258

F4 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on September 29, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

Read SEC document
November 02, 2025 Filed Nov 4, 2025 16:15 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionRestricted Stock Units · Derivative 1,835 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-048856 · wk-form4_1762290934.xml · derivative · entry 3

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,835 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on November 2, 2025.

F5 · derivative.expiration_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on November 2, 2025.

Read SEC document
November 02, 2025 Filed Nov 4, 2025 16:15 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionCommon Stock 1,835 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-048856 · wk-form4_1762290934.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,923

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on November 2, 2025.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · balance_after: Includes 2,088 shares acquired under the Issuer's 2019 Employee Stock Purchase Plan at a weighted average price of $4.26.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 17:00 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 GrantRestricted Stock Units · Derivative 50,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-081722 · ownership.xml · derivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: Award vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F2 · derivative.expiration_date: Award vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 19:00 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 SaleCommon Stock 272 $4.91 $1,335.52
Disclosure

SEC source: 0000950170-25-034016 · ownership.xml · nonDerivative · entry 2

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,000

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 19:00 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionRestricted Stock Units · Derivative 919 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-034016 · ownership.xml · derivative · entry 3

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 919 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on March 3, 2025

F4 · derivative.expiration_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on March 3, 2025

Read SEC document
March 03, 2025 Filed Mar 5, 2025 19:00 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionCommon Stock 919 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-034016 · ownership.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,272

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on March 3, 2025.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 22, 2025 Filed Jan 22, 2025 21:00 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 SaleCommon Stock 8,928 $4.79 $42,765.12
Disclosure

SEC source: 0000950170-25-008014 · ownership.xml · nonDerivative · entry 2

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,353

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

Read SEC document
January 20, 2025 Filed Jan 22, 2025 21:00 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionRestricted Stock Units · Derivative 14,908 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-008014 · ownership.xml · derivative · entry 5

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,815

Underlying: Common Stock · 14,908 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F6 · derivative.exercise_date: On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F6 · derivative.expiration_date: On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
January 20, 2025 Filed Jan 22, 2025 21:00 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionRestricted Stock Units · Derivative 8,427 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-008014 · ownership.xml · derivative · entry 4

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,850

Underlying: Common Stock · 8,427 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F5 · derivative.expiration_date: On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
January 20, 2025 Filed Jan 22, 2025 21:00 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionRestricted Stock Units · Derivative 1,977 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-008014 · ownership.xml · derivative · entry 3

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,978

Underlying: Common Stock · 1,977 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
January 20, 2025 Filed Jan 22, 2025 21:00 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionCommon Stock 25,312 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-008014 · ownership.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,281

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2025.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
November 04, 2024 Filed Nov 5, 2024 19:14 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 SaleCommon Stock 588 $8.19 $4,815.72
Disclosure

SEC source: 0000950170-24-121727 · ownership.xml · nonDerivative · entry 2

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,969

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

Read SEC document
November 02, 2024 Filed Nov 5, 2024 19:14 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionRestricted Stock Units · Derivative 1,836 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-121727 · ownership.xml · derivative · entry 3

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,835

Underlying: Common Stock · 1,836 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
November 02, 2024 Filed Nov 5, 2024 19:14 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionCommon Stock 1,836 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-121727 · ownership.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,557

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on November 2, 2024.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
August 22, 2024 Filed Aug 23, 2024 07:30 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 GrantRestricted Stock Units · Derivative 44,723 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-100018 · ownership.xml · derivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,723

Underlying: Common Stock · 44,723 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F2 · derivative.expiration_date: Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
June 10, 2024 Filed Jun 11, 2024 17:13 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 SaleCommon Stock 93 $11.79 $1,096.47
Disclosure

SEC source: 0000950170-24-072052 · ownership.xml · nonDerivative · entry 2

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,721

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.70 to $12.00. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

Read SEC document
June 07, 2024 Filed Jun 11, 2024 17:13 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionRestricted Stock Units · Derivative 301 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-072052 · ownership.xml · derivative · entry 3

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 301 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on June 7, 2024.

F5 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on June 7, 2024.

Read SEC document
June 07, 2024 Filed Jun 11, 2024 17:13 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionCommon Stock 301 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-072052 · ownership.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,814

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2024.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
May 08, 2024 Filed May 8, 2024 20:25 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 GrantCommon Stock 833 $12.00 $9,996.00
Disclosure

SEC source: 0000950170-24-056138 · ownership.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,513

F1 · shares: Represents shares purchased through a definitive subscription agreement, pursuant to which the Issuer agreed to issue and sell shares of its common stock in a non-brokered private placement to certain members of its management.

Read SEC document
May 02, 2024 Filed May 3, 2024 18:33 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 SaleCommon Stock 272 $10.32 $2,807.04
Disclosure

SEC source: 0000950170-24-053115 · ownership.xml · nonDerivative · entry 2

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,680

F4 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.11 to $10.53. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

Read SEC document
May 01, 2024 Filed May 3, 2024 18:33 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 SaleRestricted Stock Units · Derivative 918 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-053115 · ownership.xml · derivative · entry 3

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 919

Underlying: Common Stock · 918 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F6 · derivative.exercise_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F6 · derivative.expiration_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
May 01, 2024 Filed May 3, 2024 18:33 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionCommon Stock 918 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-053115 · ownership.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,952

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting of Restricted Stock Units ("RSUs") on March 3, 2024, and subsequent settlement of such vested RSUs on May 1, 2024.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · balance_after: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split.

Read SEC document
April 18, 2024 Filed Apr 22, 2024 21:12 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 GrantRestricted Stock Units · Derivative 25,277 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-046597 · ownership.xml · derivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,277

Underlying: Common Stock · 25,277 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F2 · derivative.expiration_date: Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
January 22, 2024 Filed Jan 23, 2024 19:15 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 SaleCommon Stock 21,287 $0.36 $7,663.32
Disclosure

SEC source: 0001209191-24-002117 · doc4.xml · nonDerivative · entry 2

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 151,028

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

Read SEC document
January 20, 2024 Filed Jan 23, 2024 19:15 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionRestricted Stock Units · Derivative 59,345 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-002117 · doc4.xml · derivative · entry 3

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,655

Underlying: Common Stock · 59,345 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F4 · derivative.exercise_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
January 20, 2024 Filed Jan 23, 2024 19:15 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionCommon Stock 59,345 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-002117 · doc4.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 172,315

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
November 03, 2023 Filed Nov 6, 2023 17:09 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 SaleCommon Stock 16,023 $0.40 $6,409.20
Disclosure

SEC source: 0001209191-23-054552 · doc4.xml · nonDerivative · entry 2

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,970

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.

F3 · shares: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.

Read SEC document
November 02, 2023 Filed Nov 6, 2023 17:09 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionRestricted Stock Units · Derivative 55,077 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-054552 · doc4.xml · derivative · entry 3

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,123

Underlying: Common Stock · 55,077 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F4 · derivative.exercise_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
November 02, 2023 Filed Nov 6, 2023 17:09 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionCommon Stock 55,077 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-054552 · doc4.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,993

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on November 2, 2023.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
August 31, 2023 Filed Sep 5, 2023 16:16 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 GrantCommon Stock 5,443 $0.39 $2,122.77
Disclosure

SEC source: 0001209191-23-048150 · doc4.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,916

F1 · kind: These shares were acquired under the Issuer's 2019 Employee Stock Purchase Plan subsequent to the Reporting Person's Form 4 filed on June 9, 2023.

Read SEC document
June 08, 2023 Filed Jun 9, 2023 16:15 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 SaleCommon Stock 13,361 $0.75 $10,020.75
Disclosure

SEC source: 0001209191-23-035789 · doc4.xml · nonDerivative · entry 3

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,473

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 16:15 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionRestricted Stock Units · Derivative 9,044 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035789 · doc4.xml · derivative · entry 5

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,045

Underlying: Common Stock · 9,044 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F5 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F5 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 16:15 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionRestricted Stock Units · Derivative 22,727 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035789 · doc4.xml · derivative · entry 4

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,727 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F4 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 16:15 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionCommon Stock 9,044 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-035789 · doc4.xml · nonDerivative · entry 2

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 81,834

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 16:15 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionCommon Stock 22,727 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-035789 · doc4.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 72,790

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 17:19 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 SaleCommon Stock 12,172 $1.07 $13,024.04
Disclosure

SEC source: 0001209191-23-016866 · doc4.xml · nonDerivative · entry 3

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,063

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 17:19 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionRestricted Stock Units · Derivative 27,558 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016866 · doc4.xml · derivative · entry 4

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,101

Underlying: Common Stock · 27,558 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 17:19 UTC PRECISION BIOSCIENCES INC DTIL · Entity 6284 Exercise / conversionCommon Stock 27,558 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-016866 · doc4.xml · nonDerivative · entry 2

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,235

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 3, 2023.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.